QSS
ANAB icon

Quantitative Systematic Strategies’s AnaptysBio ANAB Stock Holding History

Quantitative Systematic Strategies’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,574
Closed -$258K – 464
2019
Q2 		$258K Buy
+4,574
New +$329K 0.05% 364
2018
Q4 		– Sell
-2,051
Closed -$205K – 685
2018
Q3 		$205K Sell
2,051
-915
-31% -$75.9K 0.04% 520
2018
Q2 		$211K Buy
+2,966
New +$249K 0.04% 548

Other funds holding ANAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Quantitative Systematic Strategies's ANAB Position: Q3 2019 in Review

Quantitative Systematic Strategies sold out of AnaptysBio (ANAB) in Q3 2019, closing a stake of 4,574 shares — an estimated $258K sold.

Quantitative Systematic Strategies first reported a position in ANAB in Q2 2018 and held it in 3 quarters. The position peaked at $258K in Q2 2019. 119 funds tracked by Wall St. Rank hold ANAB as of Q3 2019.

  • Quantitative Systematic Strategies reported no remaining AnaptysBio position as of Q3 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 4,574 AnaptysBio shares in Q3 2019, an estimated $258K.
  • Quantitative Systematic Strategies first reported a position in AnaptysBio in Q2 2018 and held it in 3 quarters.
  • Quantitative Systematic Strategies's AnaptysBio position peaked at $258K in Q2 2019.
  • 119 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2019, filed 7 Nov 2019.